Coronary revascularization in Japan. Part 1: survey of facilities during 1997

M Shihara1, H Tsutsui, M Tsuchihashi

  • 1Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Insights

Coronary revascularization, particularly percutaneous coronary intervention (PCI), is highly utilized in Japan. However, most facilities performing these procedures handle low annual volumes, with limited surgical backup available.

Area of Science:

  • Cardiology
  • Health Services Research
  • Interventional Cardiology

Background:

  • Coronary artery disease (CAD) is a leading cause of death in industrialized nations like Japan.
  • Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are common treatments for CAD.
  • Data on the utilization and facility-level details of revascularization therapies in Japan is scarce.

Purpose of the Study:

  • To conduct a nationwide survey on the use of coronary revascularization procedures and the characteristics of performing facilities in Japan.
  • To assess the volume of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) procedures performed.
  • To evaluate the distribution and capacity of facilities offering these advanced cardiac interventions.

Main Methods:

  • A nationwide survey was conducted in 1997 by the Japanese Coronary Intervention Study (JCIS) Group.
  • Questionnaires were distributed to hospitals performing PCI and/or CABG.
  • Data collected included the number of procedures and facility-specific information.

Main Results:

  • A total of 109,788 PCIs and 17,667 CABGs were reported.
  • The rates per million population were 870 for PCI and 140 for CABG, with a PCI to CABG ratio of 6.2.
  • A significant proportion of facilities (44% for PCI, 77% for CABG) performed 50 or fewer procedures annually, and only 50% of PCI labs had on-site surgical backup.

Conclusions:

  • Coronary revascularization, especially PCI, is widely used in Japan.
  • Despite high utilization, many facilities operate at low annual volumes.
  • Further investigation into the implications of low-volume practice and resource availability is warranted.

Related Concept Videos

Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...